大秦帝国

新加坡的医疗成本不断上涨，究竟是什么导致的？_我的网站

A |     Balakrishna’s latest film Akhanda 2 released on Friday. The premieres of the devotional action entertainer (on Thursday) collected around Rs 8 crore. The numbers demonstrate Balakrishna-star power at the box office. The film opened to solid numbers on the first day (Friday) collecting Rs 22 core.          Akhanda 2 Two days box office collections     After Akhanda 2 opened to mixed response and criticism on Friday, trade pundits predicted that the Balakrishna-starrer would witness a sharp decline on the second day (Saturday). But much to everyone’s surprise, Akhanda 2 held its ground and stood firm. The Boyapati Srinu directorial managed to collect Rs 15.5 crore on day 2 despite the negativity that surrounded. This takes the overall film’s net collections to Rs 46 crore (including premieres) in India. Although the film witnessed a 30 per cent drop in collections, the decline was not as significant as predicted.                    RSS chief lauds Akhanda 2     Akhanda 2 sales on the ticketing portal BookMyShow in the last 24 hours alone stand close to 261K, demonstrating Balakrishna’s star power at the box office. With Sunday too being a holiday, the Akhanda 2 would cross the Rs 50 crore mark comfortably. In overseas too, Akhanda 2 opened to a good response. The film collected around $900K and is poised for better numbers in the weekend. Fans of Balakrishna are appreciating his performance in the action sequences and the devotional element in the story. With no big-ticket release around, makers are hoping that the film will find more love with a rise in theatrical footfalls.RSS Chief Mohan Bhagwat heaped praises on Akhanda 2. Showing appreciation for the film, he expressed hope that more films that are rooted in values would arrive in theatres in the future. Director Boyapati Srinu stated that blending traditions, spiritual themes and patriotism with a contemporary narrative style worked in their favour.Also Read: Akhanda 2 Review: An Unsubtle War Against Terror and Logic。

B |     新加坡的医疗成本不断上涨，引发了广泛的社会关注。而背后潜藏的主要问题——健康保险中的“按收费”模式，正逐渐成为国家金融灾难的潜在威胁。

C | 1. “按收费”计划的起源与问题2005年，新加坡健康保险领域的新秀Aviva引入了“按收费”计划，打破了健康保险市场的格局。

D | 该计划允许保险公司为医生和医院批准的任何治疗买单，导致医疗成本迅速上涨。

E | 这种模式让医生和医院可以选择最昂贵的治疗方案，而患者则因相信“最好的治疗”而积极参与。

F | 结果，医疗费用激增，公共医疗支出大幅攀升，最终负担转嫁给了消费者。数据显示，自2009年以来，政府在医疗保健方面的支出已增加了四倍，这种不可持续的增长趋势引发了社会的广泛担忧。来源：clema risk solutions2. 成本上升的背后：谁在为“按收费”买单随着“按收费”计划的普及，私立医院的医疗费用远远超过了公立医院，导致整体医疗成本的大幅上涨。研究表明，有“按收费”保险的患者，其医疗支出比没有此类保险的患者高出25%。这一问题引发了政府的关注。李显龙资政呼吁遏制过度治疗和过度开药，以控制医疗成本的攀升。然而，政治意愿的不足使得问题迟迟未得到根本解决。

G | 在这一背景下，政府近年来尝试了一些零碎的措施，例如限制医生选择，但这些措施效果有限，未能真正解决成本上升的核心问题。来源：联合早报3. 变革迫在眉睫：如何解决“按收费”问题要解决医疗成本上升的问题，必须从根本上改革“按收费”保险计划。我的建议是，取消在综合盾计划中使用MediSave资金的“按收费”覆盖范围，转而采用更具成本效益的计划。此外，保险计划的可移植性问题也需要得到解决。新加坡精算协会的研究表明，提升保险的可移植性将有助于增强市场竞争，允许新加坡人选择更适合的保险产品。总之，取消“按收费”计划和提升保险的可移植性，将是解决新加坡医疗成本问题的关键举措。这是一场必须进行的改革，为了全社会的利益，迫切需要采取行动。

H | 来源：联合早报面对日益严峻的医疗成本问题，新加坡亟需对现有的健康保险体系进行全面改革。只有通过各方的共同努力，才能为全体居民提供可持续的、负担得起的医疗保障。参考资料：1. Commentary: To contain spiralling healthcare costs in Singapore, we must remove the original sin，channelnewsasia。

Current article:http://ddl41te.cheshenzhuaduanza.buzz/cco/s99y9ja.html

Published on:04:48:50